Peptides as 'specialized supplements': what fitness creators get wrong

What did @jimmyqueenfitness actually say?

The creator laid out a six-compound protocol from a telehealth company called Transcend, organized into three categories: recovery, health, and body composition. For recovery, he named BPC-157 and TB-500. For general health, glutathione and NAD+. For fat loss and muscle building, "Tessamorelin and IGF-1, bro. The Lamborghini of peptides right there." His framing: these compounds help him look better, feel better, and be healthier in 2025. He calls them "specialized supplements" in the caption, though most of these are not supplements, they are prescription compounds or unregulated research chemicals depending on jurisdiction.

He is also clearly in a paid or affiliate relationship with Transcend. That does not automatically make his claims wrong, but it means his enthusiasm is not independent. Worth flagging before we get into the science.

Does the science back this up?

It depends heavily on which compound you are asking about. NAD+ and glutathione have the strongest evidence base of the six. The peptide claims, particularly around IGF-1 for fat loss and muscle building, are where the gap between gym-world hype and actual clinical data gets wide.

BPC-157 has shown genuine tissue-repair and anti-inflammatory effects in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), but human randomized controlled trials are essentially nonexistent. TB-500, or its active fragment Thymosin Beta-4, has early wound-healing data in humans for specific conditions like dry eye, but not for general athletic recovery. NAD+ precursor supplementation does have meaningful human data supporting cellular energy metabolism and some aging biomarkers (Yoshino et al., 2021, Science). Tesamorelin is FDA-approved, but specifically for HIV-associated lipodystrophy, not general fat loss. IGF-1 as a standalone injectable is a different story, discussed below.

What did they get wrong (or right)?

The BPC-157 and TB-500 recovery framing is overstated but not absurd. They got the mechanism directionally right. These peptides do appear to modulate inflammation and support tissue repair. The problem is calling them "hands down the best" without acknowledging that this is almost entirely preclinical data. No human trial has established them as superior to established recovery interventions.

Tesamorelin is a legitimate pharmaceutical. It is a growth hormone releasing hormone analog with actual FDA approval and actual clinical trials behind it. Lumping it in as a general "burn fat, build muscle" tool, though, strips away important context. It was studied for a specific patient population, not healthy adults chasing body composition goals.

The IGF-1 claim is the biggest problem in this video. IGF-1 is not a peptide you casually stack for aesthetics. Elevated IGF-1 has been associated with increased cancer risk in observational data (Renehan et al., 2004, Lancet). Calling it "the Lamborghini of peptides" without any safety caveat is irresponsible. The creator says "do your research," but his audience is unlikely to find the Lancet meta-analysis on their own.

NAD+ and glutathione as health-supporting compounds: mostly fair. Reasonable things to include in a longevity-oriented protocol, with appropriate medical supervision.

What should you actually know?

Most of these compounds exist in a regulatory gray zone. BPC-157 and TB-500 are not FDA-approved for any use in humans. They are sold as research chemicals or compounded by pharmacies operating under varying legal interpretations. That does not make them useless, but it does mean quality control, dosing standards, and long-term safety data are thin to nonexistent.

Tesamorelin is the exception. It has an FDA approval, which means there is actual manufacturing oversight and clinical trial data. If someone is going to use a GHRH analog, tesamorelin is arguably the one with the most legitimate evidence behind it, just not for the reasons this video implies.

IGF-1 injections warrant a serious conversation with a physician who understands oncology risk, not a TikTok endorsement. Any telehealth platform prescribing standalone IGF-1 for body composition should be disclosing this risk clearly and explicitly.

The broader issue: "specialized supplements" is a marketing phrase. These are pharmacologically active compounds with real physiological effects and real risk profiles. Framing them as upgrades to your supplement stack undersells what they actually are and overstates what we know about their long-term safety in healthy humans.